In this Review:
Varying clinical situations and outcomes with tFL
G-CSF successfully mobilises PBSC . . .
. . . and CD34+ cells
BCR-ABL1 levels during imatinib guide treatment decisions
Improving the sensitivity of the qPCR assay for CML
Eltrombopag looks promising in severe persistent ITP
High relapse rates in paediatric Ph-like ALL
CAR T-cell immunotherapy: impressive responses in ALL
Management of older patients with AML
Managing and diagnosing HIT in the ICU patient
Rivaroxaban effective in refractory HIT
Please login below to download this issue (PDF)